Smith-Jones et al. reported PET imaging of 68Ga-labeled F(ab′)2 fragments of Herceptin to determine the kinetics of loss and recovery of HER2 expression in response to the Hsp90 inhibitor 17-AAG in BT-474 human breast cancer xenografts [52]. This evidence concerns the gene ERBB2 and breast carcinoma.